Benzinga | Mar 11, 2021 04:01PM EST

Champions Oncology Q3 Adj. EPS $0.07 Beats $0.01 Estimate, Sales $10.80M Beat $10.14M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.01 by 600 percent. This is a 133.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $10.80 million which beat the analyst consensus estimate of $10.14 million by 6.51 percent. This is a 19.84 percent increase over sales of $9.01 million the same period last year.